These findings reveal an ancillary role for decreased L1CAM signaling in advanced pancreatic cancer to promote extracellular matrix remodeling that enables invasive tumor growth by overcoming microenvironment-imposed proliferation restraints. The gene discussed is L1CAM; the disease is neoplasm.